Article
Implication of Unfolded Protein Response and Autophagy in the Treatment of BRAF Inhibitor Resistant Melanoma.
Anti-cancer agents in medicinal chemistry - 1 Jan 2016
Meng Xiao-Xiao, Xu Hong-Xi, Yao Mu, Dong Qihan, Zhang Xu Dong
Abstract excerpt
The continuous activation of the mitogen-activated protein kinase signaling cascade, typified by the BRAFV600E mutation, is one of the key alterations in melanoma. Accordingly, two BRAF inhibitors (BRAFi), vemurafenib and dabrafenib are utilized to treat melanoma and resulted in an excellent clinical outcome. However, the clinical success is not long-lasting, and the BRAFi resistance and disease progression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
